VCYT Veracyte, Inc. | US92337F1075
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 654.944.910 | 585.451.600 | 11.87% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 1,89 | 1,80 | 4.64% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 11 | 11 | 0.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |